Medication info
Dapagliflozin Metformin Extended-release Tablets 10/1000 Milligrams

Dapagliflozin Metformin Extended-release Tablets 10/1000 Milligrams

Prescription medicationTabletOral
Ingredient · strength
Dapagliflozin citric acid›14.7mg / 1 tabletMetformin Hydrochloride with Colloidal Anhydrous Silica›1010mg / 1 tablet
Manufacturer / importer
Donggu Bio Pharmaceutical Co., Ltd.
Appearance
Yellow or dark yellow, biconvex oval film-coated tablets
Packaging
30 tablets/bottle
Approval status
Active

MFDS item code 202204359 · Approved 2022.12.05 · Insurance code 657308870

Summary

Main use
Improvement of glycemic control in adults with type 2 diabetes mellitus
Who takes it
Adults
Adult dose
The dose of this medication should be individualized based on the patient's current treatment regimen, efficacy, and tolerability, without exceeding the maximum recommended doses of dapagliflozin 10mg and extended-release metformin 2000mg. This medication is generally administered once daily with the evening meal. The maximum dose of this medication is dapagliflozin 10mg/extended-release metformin 2000mg once daily, administered as 2 tablets of 5mg/1000mg. Patients with no prior experience of antidiabetic drug therapy for whom adequate glycemic control cannot be achieved with monotherapy: When used as initial therapy in patients with no prior experience of antidiabetic drug therapy, the recommended starting dose of this medication is 1 tablet of 5mg/500mg or 10mg/500mg once daily. The dose should be adjusted gradually to reduce gastrointestinal adverse reactions associated with metformin. For patients receiving metformin, the recommended dose of dapagliflozin is 10mg once daily, and the dose of this medication should provide the same dose of metformin they were taking or an appropriately equivalent therapeutic dose. When switching from immediate-release to extended-release metformin, glycemic control should be closely monitored and the dose adjusted as appropriate. For patients switching from combination therapy with dapagliflozin and metformin to this medication, treatment may be initiated at the doses of dapagliflozin and metformin they were previously receiving. When switching from immediate-release to extended-release metformin, glycemic control should be closely monitored and the dose adjusted as appropriate. When this medication is used in combination with insulin or an insulin secretagogue such as a sulfonylurea, a lower dose of insulin or the insulin secretagogue may be considered to reduce the risk of hypoglycemia. Renal impairment No dose adjustment is necessary in patients with mild renal impairment. In patients with an estimated glomerular filtration rate (eGFR) of 45 mL/min/1.73 m2 or higher and less than 60 mL/min/1.73 m2 who do not have other conditions that may increase the risk of lactic acidosis, the starting dose of metformin hydrochloride, a component of this medication, is 500mg once daily, and the maximum daily dose is 1000mg. Administration of this medication is not recommended in patients with an eGFR below 45 mL/min/1.73m2. If the estimated glomerular filtration rate (eGFR) falls below 45 mL/min/1.73m2, administration of this medication should be discontinued immediately. Renal function should be assessed every 3~6 months. Elderly patients Because metformin is excreted by the kidneys and renal function is likely to decline in elderly patients, this medication should be used with caution as age increases (see Precautions for Use, 9. Administration to Elderly Patients, Patient subsection).

Ingredients

Manufacturer
Donggu Bio Pharmaceutical Co., Ltd.

Efficacy & effects

Improvement of glycemic control in adults with type 2 diabetes mellitus

  • Type 2 diabetes
  • blood sugar control disorder
  • cardiovascular diseases
  • cardiovascular risk factors
View approved original text

This medication is prescribed to aid in blood sugar control for patients with type 2 diabetes who are using dapagliflozin and metformin together. It helps to effectively manage blood sugar when used in conjunction with basic treatment methods such as diet and exercise. It is particularly used in patients whose blood sugar is not well controlled and who have cardiovascular disease or risk factors. However, it is important to follow the guidance of a healthcare professional regarding the impact on cardiovascular health. This medication is used to improve blood sugar control in patients with type 2 diabetes.

How to take

Adult dose

The dose of this medication should be individualized based on the patient's current treatment regimen, efficacy, and tolerability, without exceeding the maximum recommended doses of dapagliflozin 10mg and extended-release metformin 2000mg. This medication is generally administered once daily with the evening meal. The maximum dose of this medication is dapagliflozin 10mg/extended-release metformin 2000mg once daily, administered as 2 tablets of 5mg/1000mg. Patients with no prior experience of antidiabetic drug therapy for whom adequate glycemic control cannot be achieved with monotherapy: When used as initial therapy in patients with no prior experience of antidiabetic drug therapy, the recommended starting dose of this medication is 1 tablet of 5mg/500mg or 10mg/500mg once daily. The dose should be adjusted gradually to reduce gastrointestinal adverse reactions associated with metformin. For patients receiving metformin, the recommended dose of dapagliflozin is 10mg once daily, and the dose of this medication should provide the same dose of metformin they were taking or an appropriately equivalent therapeutic dose. When switching from immediate-release to extended-release metformin, glycemic control should be closely monitored and the dose adjusted as appropriate. For patients switching from combination therapy with dapagliflozin and metformin to this medication, treatment may be initiated at the doses of dapagliflozin and metformin they were previously receiving. When switching from immediate-release to extended-release metformin, glycemic control should be closely monitored and the dose adjusted as appropriate. When this medication is used in combination with insulin or an insulin secretagogue such as a sulfonylurea, a lower dose of insulin or the insulin secretagogue may be considered to reduce the risk of hypoglycemia. Renal impairment No dose adjustment is necessary in patients with mild renal impairment. In patients with an estimated glomerular filtration rate (eGFR) of 45 mL/min/1.73 m2 or higher and less than 60 mL/min/1.73 m2 who do not have other conditions that may increase the risk of lactic acidosis, the starting dose of metformin hydrochloride, a component of this medication, is 500mg once daily, and the maximum daily dose is 1000mg. Administration of this medication is not recommended in patients with an eGFR below 45 mL/min/1.73m2. If the estimated glomerular filtration rate (eGFR) falls below 45 mL/min/1.73m2, administration of this medication should be discontinued immediately. Renal function should be assessed every 3~6 months. Elderly patients Because metformin is excreted by the kidneys and renal function is likely to decline in elderly patients, this medication should be used with caution as age increases (see Precautions for Use, 9. Administration to Elderly Patients, Patient subsection).

Precautions

This medication may very rarely cause a serious side effect known as lactic acidosis, which can lead to death. When used in conjunction with other diabetes medications, serious hypoglycemia may occur, so caution is advised. Patients who are allergic to any component of this medication or who have severely impaired kidney function, dehydration, or serious infections should not use it. Additionally, patients with acute myocardial infarction or sepsis, type 1 diabetes patients, and women who are pregnant or breastfeeding should not take this medication. Prior to and after procedures involving contrast media, this medication should be temporarily discontinued, and it should be resumed only after confirming normal kidney function. Patients with low fluid volume or poor kidney function should carefully assess their condition before using this medication, and should periodically check blood pressure and kidney function during treatment. Patients who have low blood pressure or are taking diuretics need to be cautious due to the risk of dehydration or hypotension. This medication may increase the risk of genital infections and urinary tract infections, and treatment should be sought immediately if symptoms of infection appear. During the use of this medication, vitamin B12 levels may decrease, so regular testing should be conducted if necessary. Excessive alcohol should be avoided, as it may increase the risk of side effects associated with this medication. When used alongside insulin or sulfonylureas, the risk of hypoglycemia may require dose adjustments. Women who are pregnant or may become pregnant should not use this medication, and breastfeeding mothers should avoid it as well. Elderly patients may have decreased kidney function, so kidney function should be frequently monitored and dosing should be carefully adjusted when using this medication. In case of overdose, seek medical attention immediately for appropriate treatment, and dialysis may be beneficial if needed. Keep this medication out of the reach of children, and store it in its original container to prevent quality degradation or misuse. Caution is needed when driving or operating machinery because dizziness may occur.

Side effects

Severe lactic acidosis, severe hypoglycemia, vulvovaginitis, balanitis and related genital infections, urinary tract infections, fungal infections, hypoglycemia, reduced fluid volume, thirst, diabetic ketoacidosis, dizziness, constipation, dry mouth, low back pain, dysuria, polyuria, nocturia, vulvar pruritus, genital pruritus, increased hematocrit, decreased estimated glomerular filtration rate early in treatment, dyslipidemia, increased serum creatinine early in treatment, elevated blood urea, weight loss, ketosis, urosepsis, pyelonephritis, acute renal injury, renal dysfunction, rash, diarrhea, nausea, vomiting, decreased vitamin B12, Guillain-Barré syndrome, bacterial pneumonia, sialadenitis, tendinitis, chest pain, thermal burns, wrist fractures, gastrointestinal stromal tumors, lung malignancies, uterine fibroids, atrial fibrillation, acute cholecystitis, epigastric pain, dyspepsia, abdominal discomfort, abdominal pain, gastric ulcers, irritable bowel syndrome, salivary gland masses, toothache, headache, facial paralysis, peripheral neuropathy, sensory disturbances, drowsiness, tremor, nasopharyngitis, pharyngitis, adenoviral conjunctivitis, shingles, pneumonia, rhinitis, elevated alanine aminotransferase, increased blood sugar, arthralgia, myalgia, fibromyalgia syndrome, osteoarthritis, osteochondrosis, limb pain, periarticular inflammation, tendinitis, trigger finger, weakness, fatigue, peripheral edema, swelling, pain, vitamin D deficiency, hyperglycemia, urethral syndrome, cough, hyperventilation, skin abrasions, itching, palpitations, insomnia, type 2a hyperlipidemia, sensorineural hearing loss

Not everyone experiences these, and they can vary from person to person.

Storage

This medication may be sensitive to air and moisture, so it should be stored in a tightly closed container. It is advisable to maintain a storage temperature between 1 and 30 degrees Celsius. This will help preserve the medication's effectiveness and safety for a longer period.

Appearance and packaging

Appearance

Yellow or dark yellow, biconvex oval film-coated tablets

Package unit

30 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.